Anti-PD-L1 antibodies atezolizumab, avelumab and durvalumab currently... | Download Scientific Diagram
Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC | NEJM
Ongoing clinical trials of PD-1 and PD-L1 inhibitors for lung cancer in China | Journal of Hematology & Oncology | Full Text
Atezolizumab - Wikipedia
Atezolizumab Versus Chemotherapy in Patients with Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: A Long-term Overall Survival and Safety Update from the Phase 3 IMvigor211 Clinical Trial - European Urology
Profile of atezolizumab in the treatment of metastatic non-small-cell | DDDT
Ongoing clinical trials with PD-L1 inhibitors in multiple myeloma... | Download Table
FLASCO / Atezolizumab Clinical Trials
Overview of listed clinical trials for Atezolizumab, Nivolumab, and... | Download Scientific Diagram
Atezolizumab Versus Docetaxel in Pretreated Patients With NSCLC: Final Results From the Randomized Phase 2 POPLAR and Phase 3 OAK Clinical Trials - Journal of Thoracic Oncology
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma | NEJM
Ongoing trials of atezolizumab in NSCLC | Download Table
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial | Nature Medicine
Atezolizumab for Urinary Bladder Cancer Clinical Trial | Power
IMpower150, IMpower110, & OAK Clinical Trial Designs | TECENTRIQ® ( atezolizumab)
Study schematics of ongoing Phase iii trials of atezolizumab in... | Download Scientific Diagram
IMpower150, IMpower110, & OAK Clinical Trial Designs | TECENTRIQ® ( atezolizumab)
Phase II study of atezolizumab with bevacizumab for non-squamous non-small cell lung cancer with high PD-L1 expression (@Be Study) | Journal for ImmunoTherapy of Cancer
Smoking and immunotherapy efficacy in lung cancer by PDL1 subgroups: An individual participant data meta-analysis of atezolizumab clinical trials - European Journal of Cancer
History of PD-1 research. Abbreviations: FIM, first in man; approved,... | Download Scientific Diagram
Atezolizumab plus Bevacizumab combination therapy compared to Sorafenib and Atezolizumab monotherapies for treatment of unresectable or metastatic hepatocellular carcinoma - Asian Pacific Digestive Week 2021 | Kuala Lumpur
Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial - The Lancet
Clinical Activity and Safety of Atezolizumab in a Phase 1 Study of Patients With Relapsed/Refractory Small-Cell Lung Cancer - ScienceDirect
A clinical trial to compare atezolizumab with a placebo in people with head and neck cancer who are at a high risk of their cancer returning or getting worse after completion of
Tecentriq (atezolizumab) for the Treatment of Metastatic Urothelial Carcinoma (mUC) - Clinical Trials Arena
